Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

ChatGPT in Drug Discovery

31 January 2023, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

ChatGPT is a language model developed by OpenAI. It is a machine learning model that has been trained on a large dataset of human language, allowing it to generate human-like text. It can be used for a variety of natural language processing tasks such as language translation, text summarization, and question answering. In the current work we have discussed the application of ChatGPT in drug discovery.

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Version History

Jan 31, 2023 Version 1

Metrics

8,548
6,870
15
Views
Downloads

License

CC logo
CC
BY logo
BY
The content is available under CC BY 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv-2023-qgs3k
D O I: 10.26434/chemrxiv-2023-qgs3k [opens in a new tab]

Author’s competing interest statement

The author(s) have declared they have no conflict of interest with regard to this content

Ethics

The author(s) have declared ethics committee/IRB approval is not relevant to this content

Share